The cystic fibrosis lung in the era of modulator therapy: a longitudinal study of the lung bacterial and fungal microbiome and improving personalized phage therapy to treat multi-drug resistant infections Ghent University
Background and objectives
Modulator therapy in cystic fibrosis (CF) has led to a substantial clinical improvement of the CF patient population. However, there is currently lack of data and no consensus regarding the long-term impact of modulators on the lung microbiome and infections. Studies are often limited by the lack microbiological resolution, focus on single pathogens and none studied the Belgian CF population. Importantly, no ...